Nuveen, LLC Sarepta Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 352,740 shares of SRPT stock, worth $6.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
352,740Holding current value
$6.04 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding SRPT
# of Institutions
508Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$177 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$155 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$155 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$69.6 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$57.6 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.5B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...